Skip to main content
SpringerLink
Log in

The treatment of lupus nephritis in children involves corticosteroids and cytotoxic agents

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

References

  1. Adams A, MacDermott EJ, Lehman TJ. Pharmacotherapy of lupus nephritis in children: a recommended treatment approach. Drugs 2006; 66(9): 1191–207

    Article  PubMed  CAS  Google Scholar 

  2. Hejaili FF, Moist LM, Clark WF. Treatment of lupus nephritis. Drugs 2003; 63(3): 257–74

    Article  PubMed  CAS  Google Scholar 

  3. Lehman TJA, Mouradian JA. Systemic lupus erythematosus. In: Holliday M, Barratt M, Avner ED, editors. Pediatric nephrology. 4th ed. Baltimore (MD): Williams and Wilkins, 1999

    Google Scholar 

  4. Dimitrijevic J, Dukanovic L, Kovacevic Z, et al. Lupus nephritis: histopathologic features, classification and histologic scoring in renal biopsy. Vojnosanit Pregl 2002 Nov–Dec; 59(6 Suppl.): 21–31

    PubMed  Google Scholar 

  5. Barron KS, Person DA, Brewer EJ, et al. Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis. J Pediatr 1982; 101: 137–41

    Article  PubMed  CAS  Google Scholar 

  6. Hyams JS, Carey DE. Corticosteroids and growth. J Pediatr 1988; 113: 249–54

    Article  PubMed  CAS  Google Scholar 

  7. Ilowite NT. Premature atherosclerosis in systemic lupus erythematosus. J Rheumatol Suppl 2000 Apr; 58: 15–9

    PubMed  CAS  Google Scholar 

  8. Sfikakis PP, Boletis JN, Tsokos GC. Rituximab anti-B-cell therapy in systemic lupus erythematosus: pointing to the future. Curr Opin Rheumatol 2005; 17(5): 550–7

    Article  PubMed  CAS  Google Scholar 

  9. Bansal VK, Beto JA. Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kidney Dis 1997; 29(2): 193–9

    Article  PubMed  CAS  Google Scholar 

  10. Lehman TJ, Sherry DD, Wagner-Weiner L, et al. Intermittent intravenous cyclophosphamide therapy for lupus nephritis. J Pediatr 1989 Jun; 114(6): 1055–60

    Article  PubMed  CAS  Google Scholar 

  11. Lehman TJ, Onel K. Intermittent intravenous cyclophosphamide arrests progression of the renal chronicity index in childhood systemic lupus erythematosus. J Pediatr 2000; 136(2): 243–7

    Article  PubMed  CAS  Google Scholar 

  12. British national formulary. No. 52. London: The Pharmaceutical Press, 2006 Sep

  13. Lehman TJ, Edelheit BS, Onel KB. Combined intravenous methotrexate and cyclophosphamide for refractory childhood lupus nephritis. Ann Rheum Dis 2004; 63(3): 321–3

    Article  PubMed  CAS  Google Scholar 

  14. Looney RJ, Anolik JH, Campbell D et al. B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of rituximab. Arthritis Rheum 2004; 50(8): 2580–9

    Article  PubMed  CAS  Google Scholar 

  15. Marks SD, Patey S, Brogan PA, et al. B lymphocyte depletion therapy in children with refractory systemic lupus erythematosus. Arthritis Rheum 2005; 52(10): 3168–74

    Article  PubMed  CAS  Google Scholar 

  16. Buratti S, Szer S, Spencer CH, et al. Mycophenolate mofetil treatment of severe renal disease in pediatric onset systemic lupus erythematosus. J Rheumatol 2001 Sep; 28(9): 2103–8

    PubMed  CAS  Google Scholar 

  17. Fu LW, Yang LY, Chan WP, et al. Clinical efficacy of cyclosporin A neoral in the treatment of paediatric lupus nephrtitis with heavy proteinuria. Br J Rheumatol 1998; 37: 217–21

    Article  PubMed  CAS  Google Scholar 

  18. Kuiper-Geertsma DG, Derksen RHWM. Newer drugs for the treatment of lupus nephritis. Drugs 2003;63(2): 167–80

    Article  PubMed  CAS  Google Scholar 

  19. Moroni G, Tantardini F, Ponticelli C. Renal replacement therapy in lupus nephritis. J Nephrol 2003; 16: 787–91

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The treatment of lupus nephritis in children involves corticosteroids and cytotoxic agents. Drugs Ther. Perspect 23, 15–19 (2007). https://doi.org/10.2165/00042310-200723030-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200723030-00005

Search

Navigation